PATENT CLAIM ANALYSIS

Application Number: 15887651
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "093400"]

Abstract:
This application provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments, and methods for making, storing and using them, including storage, including long term storage, at ambient temperature. Compositions provided herein are useful for treating various diseases or conditions such as autism spectrum disorder, Crohn's Disease, ulcerative colitis, irritable bowel syndrome, and recurrent or primary  C. difficile  infection.

Claim (Index 22):
The pharmaceutical composition of  claim 1 , wherein said lyophilized fecal microbiota preparation comprises a selected fecal microbiota preparation from a donor.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.35714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15155628', '15606899', '13813915', '15791868', '15782519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6863224740657343
- 35 USC 102 Novelty (BERT): 0.5660141155588587
- Combined Prediction Score: 0.6742916382150468
- Mean Citation Score: 300.479142
- Max Citation Score: 453.92438
- Similarity Product: 366.8903640567231

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test